Presentation is loading. Please wait.

Presentation is loading. Please wait.

Gefitinib-Associated Propionibacterium acnes Pleural Empyema

Published bySophia Freire Modified over 5 years ago

Similar presentations

Presentation on theme: "Gefitinib-Associated Propionibacterium acnes Pleural Empyema"— Presentation transcript:

1 Gefitinib-Associated Propionibacterium acnes Pleural Empyema
Nicolas de Prost, MD, Armelle Lavolé, MD, Laurent Taillade, MD, Marie Wislez, MD, PhD, Jacques Cadranel, MD, PhD  Journal of Thoracic Oncology  Volume 3, Issue 5, Pages (May 2008) DOI: /JTO.0b013e31816e2417 Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Chest radiograph showing compartmentalized right pleural effusion with pulmonary infiltrates and reduced right lung volume (A). Transversal (B) and frontal (C) chest computed tomography scan slices showing voluminous and compartmentalized right infrapulmonary pleural effusion with mild mediastinal contralateral deviation. Journal of Thoracic Oncology 2008 3, DOI: ( /JTO.0b013e31816e2417) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Gefitinib-Associated Propionibacterium acnes Pleural Empyema"

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Lungs on Fire Journal of Thoracic Oncology

Lungs on Fire Journal of Thoracic Oncology
James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 

James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 
BRAF V600E Mutation Is not Always Present as Expected

BRAF V600E Mutation Is not Always Present as Expected
Volume 142, Issue 1, Pages (July 2012)

Volume 142, Issue 1, Pages (July 2012)
Pyomyositis of the chest wall presenting with empyema thoracis

Pyomyositis of the chest wall presenting with empyema thoracis
Stefano Schena, MD, PhD, Alexander S. Krupnick, MD 

Stefano Schena, MD, PhD, Alexander S. Krupnick, MD 
Long-Lasting Complete Remission with Tyrosine Kinase Inhibitor in Bronchioloalveolar Carcinoma with a so far Unknown EGFR Mutation  Vienna Ludovini, PhD,

Long-Lasting Complete Remission with Tyrosine Kinase Inhibitor in Bronchioloalveolar Carcinoma with a so far Unknown EGFR Mutation  Vienna Ludovini, PhD,
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Primary Tracheal Lymphoma Causing Respiratory Failure

Primary Tracheal Lymphoma Causing Respiratory Failure
Atypical Pleuropulmonary Tuberculosis Mimicking a Malignant Disease

Atypical Pleuropulmonary Tuberculosis Mimicking a Malignant Disease
Frank Detterbeck, MD  Journal of Thoracic Oncology 

Frank Detterbeck, MD  Journal of Thoracic Oncology 
Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP 

Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP 
Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease  Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease  Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

Similar presentations

Ads by Google